We hypothesized that bisphosphonates, a class of antiosteolytic drugs that affect bone cells, may block localized bone modeling in the middle ear. Prior studies have shown that transmitted pressure in the middle ear leads to osteoclastic bone resorption. Catheters were surgically implanted into the middle ear cavity (bulla) of 31 Mongolian gerbils. The animals were then divided into two groups, one subset receiving a bisphosphonate, and the other receiving no drug. Positive air pressure was applied to one middle ear, and the other side served as a control. At the end of the experimental period, tissue specimens were obtained, and histomorphometric evaluation of the ventral bullae was performed. Significant differences in osteoclast surface, osteoclast number, and mean individual osteoclast profile area led us to conclude that administration of the bisphosphonate used at the dose studied inhibits localized recruitment and activation of osteoclasts.
CholeRA. Osteoclasts in chronic otitis media, cholesteatoma, and otosclerosis. Ann Otol Rhinol Laryngol1988; 97: 661–6.
2.
MundyGRRoodmanGD. Osteoclast otogeny and function. Bone Mineral Res1987; 15: 103–8.
3.
BonucciE. New knowledge on the origin, function, and fate of osteoclasts. Clin Orthop1981; 158: 252–69.
4.
ChambersTJAliNN. Inhibition of osteoclastic motility by prostaglandins I2, F, E1, E2 and 6-oxo-E1. J Pathol1983; 139: 383–97.
5.
YonedaTMundyGR. Monocytes regulate osteoclast-activating factor production by releasing prostaglandins. J Exp Med1979; 150: 338–50.
6.
FleischH. Bisphosphonates: History and experimental basis. Bone1987; 8: 23–8.
7.
JungABisazSFleischH. The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals. Calcif Tissue Res1973; 11: 269–80.
8.
FleischH. Bisphosphonates: Mechanism of action and clinical application. In: PeckW, ed. Bone and mineral research annual 1. Amsterdam, the Netherlands: Excerpta Medica, 1983: 319–57.
9.
FelixRBettexJDFleischH. Effect of diphosphonates on synthesis of prostaglandins in cultured calvaria cells. Calcif Tissue Int1981; 33: 549–52.
10.
RaizLGMartinTJ. Prostaglandins in bone and mineral metabolism. In: PeckW, ed. Bone and mineral research annual 2. Amsterdam, the Netherlands: Excerpta Medica, 1983: 286–310.
11.
StevensonHStevensonJR. Cytotoxic and migration inhibitory effects of bisphosphonates on macrophages. Calcif Tissue Int1986; 38: 227–33.
12.
ChambersTJ. Diphosphonates inhibit bone resorption by macrophages in vitro. J Pathol1980; 132: 255–62.
13.
RoweDJHausmanE. The alteration of osteoclast morphology by diphosphonates in bone organ culture. Calcif Tissue Res1976; 20: 53–60.
14.
MillerSCJeeWS. The comparative effects of dichloromethane diphosphonate (Cl2MDP) and ethane-1-hydroxy-1,1-diphosphonate (EHDP) on growth and modeling of the rat tibia. Calcif Tissue Res1977; 23: 207–14.
15.
LowikCWBoonekampPMVan de Wee-PalsLVan de PluymGvan Treslong de GrootH BloysBijovetOL. Bisphosphonates can reduce osteoclastic resorption by two different mechanisms. Adv Exp Med Biol1986; 208: 275–81.
16.
FelixRRussellGFleischH. The effects of several diphosphonates on acid phosphohydrolases and other lysosomal enzymes. Biochim Biophys Acta1976; 429: 429–38.
17.
LernerUHLarssonA. Effects of four bisphosphonates on bone resorption, lysosomal enzyme release, protein synthesis and mitotic activities in mouse calvarial bones in vitro. Bone1987; 8: 179–89.
18.
RussellRGKisligAMCaseyPA. Effects of diphosphonates and calcitonin on the chemistry and quantitative histology of rat bone. Calcif Tissue Res1973; 11: 179–95.
19.
WolfmanDECholeRA. Osteoclast stimulation by positive middle-ear air pressure. Arch Otolaryngol Head Neck Surg1986; 112: 1037–42.
20.
CholeRAChanDE. Rapid induction of localized bone resorption in the auditory bulla of the Mongolian gerbil, Meriones unguiculatus, by increased air pressure. Calcif Tissue Int1989; 45: 318–23.
21.
LockwoodDRVogelJMSchneiderVSHulleySB. Effect of the diphosphonate EHDP on bone mineral metabolism during prolonged bed rest. J Clin Endocrinol Metab1975; 41: 533–41.
22.
WitteRS. Clodronate. A randomized study in the treatment of cancer related hypercalcemia. Arch Intern Med1987; 147: 937–9.
23.
ElomaaI. Diphosphonates for osteolytic metastases. Lancet1984; ii: 1043.
24.
BernsteinJMOkazakiTReismanRE. Prostaglandins in middle ear effusions. Arch Otolaryngol1976; 102: 257–8.
25.
JacksonRT. Pharmacological mechanisms in the eustachian tube. Ann Otol Rhinol Laryngol1971; 80: 313–8.
26.
BonucciE. The organic-inorganic relationships in bone matrix undergoing osteoclastic resorption. Calcif Tissue Res1974; 16: 13–36.
27.
FastDKFelixRDowseCNeumanWFFleischH. The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in culture. Biochem J1978; 172: 97–197.
28.
MorganDBMonodARussellRGGFleischH. Influence of dichloromethylene diphosphonate (Cl2MDP) and calcitonin on bone resorption, lactate production and phosphatase and pyrophosphatase content of mouse calvaria treated with parathyroid hormone in vitro. Calcif Tissue Res1973; 13: 287–94.
29.
SchenkRMerzRMuhlbauerRGRusseliGFleischH. Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res1973; 11: 196–214.
30.
ShinodaHAdamekGFelixRFleischHSchenkRNaganP. Structure-activity relationship of various bisphosphonates. Calcif Tissue Int1983; 35: 87–99.
31.
DouglasDLRussellRGPrestonCJ. Effects of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcemia due to primary hyperparathyroidism or malignant disease. Lancet1980; i: 1043–7.
32.
AltmanRDJohnstonCCKhairiMRWellmanHSerafiniANSankeyRR. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). N Engl J Med1973; 289: 1379–84.
33.
HoskingDJAkenJVBijvoetOLWillEJ. Paget's bone disease treated with diphosphonate and calcitonin. Lancet1976; i: 615–7.
34.
PittWR. Comparison of quantitative and visual detection of new focal bone lesions. J Nucl Med1985; 26: 230–6.
LandoMHooverLAFinermanG. Stabilization of hearing loss in Paget's disease with calcitonin and editronate. Arch Otolaryngol Head Neck Surg1988; 114: 891–4.
37.
NagerGT. Paget's disease of the temporal bone. Ann Otol Rhinol Laryngol1975; 84(suppl 22).
38.
PetrovicAGStutzmannJJShambaughGE. Experimental studies on pathology and therapy of otospongiosis. Am J Otol1985; 6: 43–50.
39.
DavisGL. Pathology of otosclerosis: A review. Am J Otolaryngol1987; 8: 273–81.
40.
BretlauPChevanceLGCausseJJorgensenMB. Bone resorption in otospongiosis. Am J Otol1982; 3: 284–9.
